180 related articles for article (PubMed ID: 29155233)
1. Autologous hematopoietic stem cell transplantation in systemic sclerosis: A reset to tolerance?
van Rhijn-Brouwer FCC; Spierings J; van Laar JM
Immunol Lett; 2018 Mar; 195():88-96. PubMed ID: 29155233
[TBL] [Abstract][Full Text] [Related]
2. The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantation.
Servaas NH; Spierings J; Pandit A; van Laar JM
Clin Exp Immunol; 2020 Jul; 201(1):34-39. PubMed ID: 31990046
[TBL] [Abstract][Full Text] [Related]
3. Analysis of immune reconstitution after autologous CD34+ stem/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4+ T cells.
Tsukamoto H; Nagafuji K; Horiuchi T; Mitoma H; Niiro H; Arinobu Y; Inoue Y; To K; Miyamoto T; Iwasaki H; Teshima T; Harada M; Akashi K
Rheumatology (Oxford); 2011 May; 50(5):944-52. PubMed ID: 21172925
[TBL] [Abstract][Full Text] [Related]
4. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial.
Brinkman DM; de Kleer IM; ten Cate R; van Rossum MA; Bekkering WP; Fasth A; van Tol MJ; Kuis W; Wulffraat NM; Vossen JM
Arthritis Rheum; 2007 Jul; 56(7):2410-21. PubMed ID: 17599770
[TBL] [Abstract][Full Text] [Related]
5. Autologous stem cell transplantation in systemic sclerosis: a systematic review.
Host L; Nikpour M; Calderone A; Cannell P; Roddy J
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):198-207. PubMed ID: 28869416
[TBL] [Abstract][Full Text] [Related]
6. Functional autoantibodies in systemic sclerosis: influence of autologous stem cell transplantation and correlation with clinical outcome.
Bankamp L; Preuß B; Pecher AC; Vogel W; Henes J; Klein R
Rheumatology (Oxford); 2023 Jun; 62(6):2168-2177. PubMed ID: 36222553
[TBL] [Abstract][Full Text] [Related]
7. Autologous stem cell transplantation for systemic sclerosis.
Farge D; Nash R; Laar JM
Autoimmunity; 2008 Dec; 41(8):616-24. PubMed ID: 18958754
[TBL] [Abstract][Full Text] [Related]
8. Autologous hematopoietic stem cell transplantation in autoimmune diseases.
Annaloro C; Onida F; Lambertenghi Deliliers G
Expert Rev Hematol; 2009 Dec; 2(6):699-715. PubMed ID: 21082959
[TBL] [Abstract][Full Text] [Related]
9. Choosing appropriate patients with systemic sclerosis for treatment by autologous stem cell transplantation.
Clements PJ; Furst DE
J Rheumatol Suppl; 1997 May; 48():85-8. PubMed ID: 9150125
[TBL] [Abstract][Full Text] [Related]
10. Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis.
Adamska JZ; Zia A; Bloom MS; Crofford LJ; Furst DE; Goldmuntz E; Keyes-Elstein L; Mayes MD; McSweeney P; Nash RA; Pinckney A; Welch B; Love ZZ; Sullivan KM; Robinson W
Ann Rheum Dis; 2023 Mar; 82(3):357-364. PubMed ID: 36241361
[TBL] [Abstract][Full Text] [Related]
11. Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathy.
Rosen O; Massenkeil G; Hiepe F; Pest S; Hauptmann S; Radtke H; Burmester G; Thiel A; Radbruch A; Heymer B; Arnold R
Bone Marrow Transplant; 2001 Mar; 27(6):657-8. PubMed ID: 11319598
[TBL] [Abstract][Full Text] [Related]
12. [Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus].
Alexander T; Arnold R; Hiepe F
Z Rheumatol; 2016 Oct; 75(8):770-779. PubMed ID: 27612476
[TBL] [Abstract][Full Text] [Related]
13. Application of stem cell transplantation in autoimmune diseases.
Ng SA; Sullivan KM
Curr Opin Hematol; 2019 Nov; 26(6):392-398. PubMed ID: 31490316
[TBL] [Abstract][Full Text] [Related]
14. Adult stem cell treatment of scleroderma.
Tyndall A; Furst DE
Curr Opin Rheumatol; 2007 Nov; 19(6):604-10. PubMed ID: 17917542
[TBL] [Abstract][Full Text] [Related]
15. Immunological reconstitution after autologous hematopoietic stem cell transplantation in patients with systemic sclerosis: relationship between clinical benefits and intensity of immunosuppression.
Bohgaki T; Atsumi T; Bohgaki M; Furusaki A; Kondo M; Sato-Matsumura KC; Abe R; Kataoka H; Horita T; Yasuda S; Amasaki Y; Nishio M; Sawada K; Shimizu H; Koike T
J Rheumatol; 2009 Jun; 36(6):1240-8. PubMed ID: 19447934
[TBL] [Abstract][Full Text] [Related]
16. Autologous hematopoietic stem cell transplantation for systemic sclerosis.
Milanetti F; Bucha J; Testori A; Burt RK
Curr Stem Cell Res Ther; 2011 Mar; 6(1):16-28. PubMed ID: 20955159
[TBL] [Abstract][Full Text] [Related]
17. [Bortezomib-based induction therapy followed by autologous hematopoietic stem cell transplantation in multiple myeloma].
Huang B; Li J; Liu J; Gu J; Zheng D; Xu D; Zou W; Wang H
Zhonghua Nei Ke Za Zhi; 2014 Nov; 53(11):865-72. PubMed ID: 25586356
[TBL] [Abstract][Full Text] [Related]
18. Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells.
Rosen O; Thiel A; Massenkeil G; Hiepe F; Häupl T; Radtke H; Burmester GR; Gromnica-Ihle E; Radbruch A; Arnold R
Arthritis Res; 2000; 2(4):327-36. PubMed ID: 11056673
[TBL] [Abstract][Full Text] [Related]
19. Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party.
Cencioni MT; Genchi A; Brittain G; de Silva TI; Sharrack B; Snowden JA; Alexander T; Greco R; Muraro PA
Front Immunol; 2021; 12():813957. PubMed ID: 35178046
[TBL] [Abstract][Full Text] [Related]
20. Progress and prospects for the use and the understanding of the mode of action of autologous hematopoietic stem cell transplantation in the treatment of multiple sclerosis.
Collins F; Kazmi M; Muraro PA
Expert Rev Clin Immunol; 2017 Jun; 13(6):611-622. PubMed ID: 28277827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
